Compounds > cbm 4a
Page last updated: 2024-09-03

cbm 4a and ifosfamide

cbm 4a has been researched along with ifosfamide in 6 studies

*Ifosfamide: Positional isomer of CYCLOPHOSPHAMIDE which is active as an alkylating agent and an immunosuppressive agent. [MeSH]

*Ifosfamide: Positional isomer of CYCLOPHOSPHAMIDE which is active as an alkylating agent and an immunosuppressive agent. [MeSH]

Compound Research Comparison

Studies
(cbm 4a)		Trials
(cbm 4a)		Recent Studies (post-2010)
(cbm 4a)		Studies
(ifosfamide)		Trials
(ifosfamide)		Recent Studies (post-2010) (ifosfamide)
8005,0451,4301,113

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's4 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kinas, RW; Kuśnierczyk, H; Misiura, K1
Juszkiewicz, M; Kleinrok, Z; Sawiniec, Z1
Konarski, L; Kowalski, P; Kuśnierczyk, H; Radzikowski, C1
Bieblová, J; Bubeník, J; Indrová, M; Jandlová, T; Jinoch, P; Mendoza, L; Mikysková, R; Pajtasz-Piasecka, E; Símová, J; Smahel, M; Vonka, V1
Bieblová, J; Indrová, M; Jandlová, T; Pajtasz-Piasecka, E; Reinis, M; Vonka, V1
Bieblová, J; Bubeník, J; Indrová, M; Kuropka, P; Pajtasz-Piasecka, E; Reinis, M; Rossowska, J1

Other Studies

6 other study(ies) available for cbm 4a and ifosfamide

ArticleYear
Studies on the side-chain hydroxylation of ifosfamide and its bromo analogue.
    Bioorganic & medicinal chemistry letters, 2002, Feb-11, Volume: 12, Issue:3

    Topics: Animals; Antineoplastic Agents, Alkylating; Hydroxylation; Ifosfamide; Isotope Labeling; Kinetics; Leukemia L1210; Mice; Microsomes, Liver; Oxidation-Reduction; Rats; Stereoisomerism; Structure-Activity Relationship

2002
Pharmacological properties of racemic chlorobromofosfamide.
    Archivum immunologiae et therapiae experimentalis, 1994, Volume: 42, Issue:5-6

    Topics: Animals; Antineoplastic Agents; Blood Proteins; Body Temperature; Body Weight; Dose-Response Relationship, Drug; Hematocrit; Hemoglobins; Ifosfamide; Lethal Dose 50; Male; Mice; Rats; Rats, Wistar; Stereoisomerism

1994
Influence of mesna on urotoxic effects of selected bromosubstituted analogs of ifosfamide.
    Archivum immunologiae et therapiae experimentalis, 1997, Volume: 45, Issue:1

    Topics: Administration, Oral; Animals; Cystitis; Edema; Female; Hemorrhage; Ifosfamide; Injections, Intraperitoneal; Lethal Dose 50; Maximum Allowable Concentration; Mesna; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Necrosis; Stereoisomerism; Urinary Bladder

1997
Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
    International journal of oncology, 2003, Volume: 22, Issue:3

    Topics: Adjuvants, Immunologic; Animals; Antigens, Neoplasm; Antineoplastic Agents, Alkylating; Cancer Vaccines; Cell Transformation, Viral; Combined Modality Therapy; Drug Screening Assays, Antitumor; Genes, MHC Class I; Genes, ras; Granulocyte-Macrophage Colony-Stimulating Factor; Histocompatibility Antigens Class I; Ifosfamide; Immunotherapy; Injections, Subcutaneous; Interleukin-12; Interleukin-2; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Oncogene Proteins, Viral; Papillomavirus E7 Proteins; Repressor Proteins; Vaccination

2003
Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours.
    International journal of oncology, 2006, Volume: 28, Issue:1

    Topics: Animals; Cancer Vaccines; Disease Models, Animal; Down-Regulation; Genes, MHC Class I; Genetic Therapy; HLA Antigens; Human papillomavirus 16; Humans; Ifosfamide; Immunotherapy; Interleukin-12; Male; Mice; Neoplasm, Residual; Neoplasms, Experimental; Tumor Cells, Cultured; Up-Regulation

2006
HPV 16-associated tumours: IL-12 can repair the absence of cytotoxic and proliferative responses of tumour infiltrating cells after chemotherapy.
    International journal of oncology, 2009, Volume: 34, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Proliferation; Cytotoxicity Tests, Immunologic; Flow Cytometry; Genetic Therapy; Human papillomavirus 16; Humans; Ifosfamide; Immunoenzyme Techniques; Immunotherapy; Interleukin-12; Lymphocytes, Tumor-Infiltrating; Male; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Papillomavirus Infections; Tumor Cells, Cultured

2009